3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
75
Burkitt Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Leukemia, Biphenotypic, Acute
16
Myelodysplastic Syndromes
13
Leukemia
10
Lymphoma, Mantle-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Myeloproliferative Disorders
6
Leukemia, Myelomonocytic, Chronic
5
Recurrence
4
Blast Crisis
4
Sarcoma, Myeloid
3
Lymphoma
3
Leukemia, Monocytic, Acute
3
Hematologic Neoplasms
3
Down Syndrome
3
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocythemia, Essential
1
Targeted Therapy
1
Interventions
pembrolizumab
2
durvalumab
2
Tretinoin
2
Paclitaxel
2
Oxaliplatin
2
Irinotecan
2
Chemoradiotherapy
2
Carboplatin
2
Capecitabine
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tislelizumab
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
relugolix
1
pexidartinib
1
pertuzumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
enzalutamide
1
dostarlimab
1
cemiplimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Cytarabine
×
90 days
×
Clear all
No trials found.